Browsing by Author Novo Nordisk AS

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
12-Jun-2004Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparumMichael Alifrangis; Inge T. Christensen; Flemming S. Jørgensen; Anita M. Rønn; Jimmy E. Weng; Ming Chen; Ib C. Bygbjerg; Worachart Sirawaraporn; Yaseelan Palarasah; Claus Koch; Kobenhavns Universitet; Copenhagen University Hospital; University of Copenhagen, Faculty of Pharmaceutical Sciences; Statens Serum Institut; Mahidol University; Novo Nordisk AS
1-Apr-2013Prophylaxis in congenital factor VII deficiency: Indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)Mariasanta Napolitano; Muriel Giansily-Blaizot; Alberto Dolce; Jean F. Schved; Guenter Auerswald; Jørgen Ingerslev; Jens Bjerre; Carmen Altisent; Pimlak Charoenkwan; Lisa Michaels; Ampaiwan Chuansumrit; Giovanni Di Minno; Ümran Caliskan; Guglielmo Mariani; Universita degli Studi dell'Aquila; CHU Montpellier; Istituto Nazionale Di Statistica, Rome; Klinikum Bremen-Mitte; Skejby Sygehus, Aarhus University Hospital; Novo Nordisk AS; Hospital Universitari Vall d'Hebron; Chiang Mai University; Robert Wood Johnson University; Mahidol University; Universita degli Studi di Napoli Federico II; Selcuk Universitesi; University of Ferrara
1-Jan-2012Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: A randomized controlled trialErich V. de Paula; Kaan Kavakli; Johnny Mahlangu; Yasmin Ayob; Steven R. Lentz; Massimo Morfini; László Nemes; Silva Z. Šalek; Midori Shima; Jerzy Windyga; Silke Ehrenforth; Ampaiwan Chuansumrit; Universidade Estadual de Campinas; Ege University Medical School; Academic Hospital; National Blood Center; University of Iowa; Azienda Ospedaliera Careggi; National Hemophilia Center; University of Zagreb School of Medicine; Nara Kenritsu Ika Daigaku Fozuku Byoin; Institute of Haematology and Transfusion Medicine, Warsaw; Novo Nordisk AS; Mahidol University
18-Dec-2014Recombinant long-acting glycoPEGylated factor IX in hemophilia B: A multinational randomized phase 3 trialPeter W. Collins; Guy Young; Karin Knobe; Faraizah Abdul Karim; Pantep Angchaisuksiri; Claus Banner; Türkiz Gürsel; Johnny Mahlangu; Tadashi Matsushita; Eveline P. Mauser-Bunschoten; Johannes Oldenburg; Christopher E. Walsh; Claude Negrier; Cardiff University; Keck School of Medicine of USC; Novo Nordisk AS; National Blood Centre; Mahidol University; Gazi University, Faculty of Medicine; University of Witwatersrand; Nagoya University Hospital; Van Creveld Haemophilia Clinic; Universitats-Klinikum Bonn und Medizinische Fakultat; The Mount Sinai Medical Center; Universite Claude Bernard Lyon 1
1-Feb-2006Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: A multicenter, randomized, double-blind, placebo-controlled trialYong Fu Shao; Jia Mei Yang; Gar Yang Chau; Yongyut Sirivatanauksorn; Shou Xian Zhong; Elisabeth Erhardtsen; Supanit Nivatvongs; Po Huang Lee; Chinese Academy of Medical Sciences; Second Military Medical University; Veterans General Hospital-Taipei; Mahidol University; Peking Union Medical College; Novo Nordisk AS; Chulalongkorn University; National Taiwan University Hospital